SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Clinical trials for SYSTEMIC INFLAMMATORY RESPONSE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC INFLAMMATORY RESPONSE SYNDROME trials appear
Sign up with your email to follow new studies for SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for dangerous pancreatitis complication
Disease control CompletedThis study tested an experimental drug called CM4620-IE in 21 people with severe pancreatitis that caused body-wide inflammation (SIRS). The goal was to see if the drug is safe and to find the best dose for future studies. Participants received the drug plus standard care or stan…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New drug shows promise for speeding recovery in severe pancreatitis
Disease control CompletedThis study tested a drug called Auxora in 216 people hospitalized with acute pancreatitis and systemic inflammatory response syndrome (SIRS), a serious body-wide inflammation. Participants received either Auxora or a placebo daily for three days. The main goal was to see if Auxor…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Heart surgery brain fog: scientists hunt for a blood test to predict it
Knowledge-focused CompletedThis study looked at 48 older adults having heart bypass surgery to see if a small molecule called microRNA-151-5p is linked to memory and thinking problems after the operation. Researchers measured levels of this molecule and inflammation in the blood before and after surgery, a…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Sponsor: Osijek University Hospital • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
New malaria drug put to the test in human trial
Knowledge-focused CompletedThis study tested a new experimental drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug works and how safe it is. The goal was to measure how the body processes the drug and how…
Matched conditions: SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:09 UTC